Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review

  • ID: 4429761
  • SWOT Analysis
  • Region: Global
  • 40 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Derma Sciences Inc
  • Johnson & Johnson
  • MORE
Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sangui Biotech International Inc (SGBI), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. SGBI's product portfolio includes artificial oxygen carriers, nano formulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. It markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. SGBI is headquartered in Witten, Nordrhein-Westfalen, Germany.

Sangui BioTech International Inc Key Recent Developments

Jul 18, 2017: Sangui Bio announces Revenues in fiscal year 2017
Feb 24, 2017: Sangui Bio announces Sales in the first half year
Jan 12, 2017: Sangui Bio announces Revenues in the first half-year
Nov 22, 2016: Sangui Bio Publishes Preliminary Figures for First Three Months of Fiscal Year 2017
Nov 22, 2016: Sangui BioTech Reports Sales of USD 9,711 in the first three months

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Derma Sciences Inc
  • Johnson & Johnson
  • MORE
Section 1 - About the Company
  • Sangui BioTech International Inc - Key Facts
  • Sangui BioTech International Inc - Key Employees
  • Sangui BioTech International Inc - Key Employee Biographies
  • Sangui BioTech International Inc - Major Products and Services
  • Sangui BioTech International Inc - History
  • Sangui BioTech International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Sangui BioTech International Inc - Business Description
  • Sangui BioTech International Inc - Corporate Strategy
  • Sangui BioTech International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Sangui BioTech International Inc - Strengths
  • Sangui BioTech International Inc - Weaknesses
  • Sangui BioTech International Inc - Opportunities
  • Sangui BioTech International Inc - Threats
  • Sangui BioTech International Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Sangui BioTech International Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 18, 2017: Sangui Bio announces Revenues in fiscal year 2017
  • Feb 24, 2017: Sangui Bio announces Sales in the first half year
  • Jan 12, 2017: Sangui Bio announces Revenues in the first half-year
  • Nov 22, 2016: Sangui BioTech Reports Sales of USD 9,711 in the first three months
  • Nov 22, 2016: Sangui Bio Publishes Preliminary Figures for First Three Months of Fiscal Year 2017
  • Oct 13, 2016: Sangui BioTech Reports Sales of USD 48,000 in fiscal year 2016
  • Jun 06, 2016: Sangui BioTech Reports Sales of USD 37,005 in the first nine months
  • Jun 06, 2016: Sangui BioTech: Third Quarter Report
  • Feb 01, 2016: Sangui BioTech International Publishes Preliminary Figures for First Half Year
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
List of Tables
  • Sangui BioTech International Inc, Key Facts
  • Sangui BioTech International Inc, Key Employees
  • Sangui BioTech International Inc, Key Employee Biographies
  • Sangui BioTech International Inc, Major Products and Services
  • Sangui BioTech International Inc, History
  • Sangui BioTech International Inc, Subsidiaries
  • Sangui BioTech International Inc, Key Competitors
  • Sangui BioTech International Inc, Ratios based on current share price
  • Sangui BioTech International Inc, Annual Ratios
  • Sangui BioTech International Inc, Annual Ratios (Cont...1)
  • Sangui BioTech International Inc, Interim Ratios
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Sangui BioTech International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sangui BioTech International Inc, Performance Chart (2013 - 2017)
  • Sangui BioTech International Inc, Ratio Charts
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Wound Management Technologies Inc
  • Johnson & Johnson
  • Derma Sciences Inc
  • Bristol-Myers Squibb Co
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll